DK0714403T3 - Vandig flerfaset isolering af polypeptid - Google Patents

Vandig flerfaset isolering af polypeptid

Info

Publication number
DK0714403T3
DK0714403T3 DK94925830T DK94925830T DK0714403T3 DK 0714403 T3 DK0714403 T3 DK 0714403T3 DK 94925830 T DK94925830 T DK 94925830T DK 94925830 T DK94925830 T DK 94925830T DK 0714403 T3 DK0714403 T3 DK 0714403T3
Authority
DK
Denmark
Prior art keywords
polypeptide
aqueous
enriched
phases
cells
Prior art date
Application number
DK94925830T
Other languages
English (en)
Inventor
Stuart Builder
Roger Hart
Philip Lester
John Ogez
David Reifsnyder
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0714403T3 publication Critical patent/DK0714403T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/804—Single cell protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94925830T 1993-08-20 1994-08-10 Vandig flerfaset isolering af polypeptid DK0714403T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/110,663 US5407810A (en) 1993-08-20 1993-08-20 Aqueous multiple-phase isolation of polypeptide
PCT/US1994/009089 WO1995006059A1 (en) 1993-08-20 1994-08-10 Aqueous multiple-phase isolation of polypeptide

Publications (1)

Publication Number Publication Date
DK0714403T3 true DK0714403T3 (da) 1999-03-22

Family

ID=22334217

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94925830T DK0714403T3 (da) 1993-08-20 1994-08-10 Vandig flerfaset isolering af polypeptid

Country Status (11)

Country Link
US (3) US5407810A (da)
EP (1) EP0714403B1 (da)
JP (1) JP3646195B2 (da)
AT (1) ATE167193T1 (da)
AU (1) AU673624B2 (da)
CA (1) CA2167910C (da)
DE (1) DE69411015T2 (da)
DK (1) DK0714403T3 (da)
ES (1) ES2119222T3 (da)
GR (1) GR3027656T3 (da)
WO (1) WO1995006059A1 (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
TW517059B (en) * 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
WO1996004556A1 (en) * 1994-08-01 1996-02-15 Hsu James T Lipoprotein cholesterol assays
EP0779927A1 (en) * 1994-09-08 1997-06-25 Chiron Corporation A method of improved production of insulin-like growth factor
GB9618952D0 (en) 1996-09-11 1996-10-23 Sandoz Ltd Process
US6756484B1 (en) 1995-04-14 2004-06-29 Cephalon, Inc. IGF-I purification process
US5650496A (en) * 1995-04-14 1997-07-22 Cephalon, Inc. IGF-I purification process
US5789213A (en) * 1995-05-11 1998-08-04 Health Research Inc. Method and compositions for high efficiency loading, transfection and fusion of cells by electric pulses
DE69630524T2 (de) * 1995-06-07 2004-08-05 Chiron Corp., Emeryville Methoden zur aufreinigung von authentischem igf aus hefewirtszellen
DE69635051T2 (de) * 1995-06-07 2006-06-14 Chiron Corp Methode zur lösung, reinigung und rückfaltung von protein
US7193042B1 (en) 1995-06-07 2007-03-20 Chiron Corporation Methods for purifying authentic IGF from yeast hosts
US7071313B1 (en) 1995-06-07 2006-07-04 Cephalon, Inc. Methods of purifying authentic IGF from yeast hosts
US5945515A (en) * 1995-07-31 1999-08-31 Chomczynski; Piotr Product and process for isolating DNA, RNA and proteins
SE9504019D0 (sv) * 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins
US5734024A (en) * 1996-04-19 1998-03-31 Boris Y. Zaslavsky Method for determining the biological activity of recombinant human growth hormone
IT1291362B1 (it) * 1997-05-13 1999-01-07 Vectorpharma Int Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi
WO2000010674A1 (en) * 1997-08-19 2000-03-02 Arnon Chait Method for evaluation of the ratio of amounts of biomolecules or their sub-populations in a mixture
US20020052026A1 (en) * 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6265542B1 (en) 1997-10-24 2001-07-24 Genentech, Inc. Purification of molecules
WO2000017353A1 (en) 1998-09-22 2000-03-30 Genentech, Inc. Ucp4
WO2000002996A2 (en) 1998-07-10 2000-01-20 Cornell Research Foundation, Inc. Recombinant constructs and systems for secretion of proteins via type iii secretion systems
DE69943058D1 (de) * 1998-11-30 2011-02-03 Genentech Inc Loslösendes protein 5 - ucp5
US7342102B2 (en) 1998-11-30 2008-03-11 Genentech, Inc. Uncoupling protein 5 (UCP5)
CA2358609A1 (en) * 1999-01-07 2000-07-13 Takeda Chemical Industries, Ltd. Process for producing activated protein
US6437101B1 (en) 1999-05-07 2002-08-20 Akzo Nobel N.V. Methods for protein purification using aqueous two-phase extraction
US7229789B1 (en) * 2001-01-19 2007-06-12 N.V. Organon Methods and compositions for extracting proteins from cells
HUP0500733A3 (en) 2001-02-09 2010-01-28 Genentech Inc Crystallization of igf-1
EP1314739A1 (en) * 2001-11-22 2003-05-28 Bayer Ag Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines
US7998705B2 (en) * 2002-08-06 2011-08-16 FUJIFILM Diosynth Biotechnologies U.S.A., Inc Increased dynamic binding capacity in ion exchange chromatography by addition of polyethylene glycol
US6924124B1 (en) * 2002-08-23 2005-08-02 Immunex Corporation Feeding strategies for cell culture
CA2526409A1 (en) * 2003-05-19 2004-12-02 Brandeis University Nucleic acid processing methods, kits and devices
US8415302B2 (en) 2004-01-28 2013-04-09 The Regents Of The University Of California Surgical applications for BMP binding protein
US8188219B2 (en) 2004-01-28 2012-05-29 The Regents Of The University Of California Bone morphogenic protein binding peptide
US8193312B2 (en) 2004-01-28 2012-06-05 The Regents Of The University Of California Bone morphogenic protein binding peptide
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
EP1761552B1 (en) 2004-06-29 2008-09-17 Ares Trading S.A. Process for the purification of il-18 binding protein
EP1853283B1 (en) * 2004-11-29 2015-09-16 The Regents of The University of California Activating extraction of demineralized bone matrix
CA2915270C (en) * 2005-08-05 2017-07-11 Amgen Inc. Stable aqueous protein or antibody pharmaceutical formulations and their preparation
US20070048786A1 (en) * 2005-09-01 2007-03-01 Arnon Chait Systems and methods for fractionation of protein mixtures
US9072709B2 (en) 2009-06-23 2015-07-07 The Regents Of The University Of California Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)
KR20170060056A (ko) * 2014-09-26 2017-05-31 질레코 인코포레이티드 가용화된 효소 및 이의 용도
ES2893293T3 (es) * 2014-10-01 2022-02-08 Impossible Foods Inc Métodos de extracción y purificación de proteínas no desnaturalizadas
JP2016172707A (ja) * 2015-03-18 2016-09-29 株式会社ＵｎｉＢｉｏ 植物体内で発現させた上皮細胞増殖因子の精製品の製造方法
US11051532B2 (en) 2017-09-22 2021-07-06 Impossible Foods Inc. Methods for purifying protein
US12011016B2 (en) 2020-09-14 2024-06-18 Impossible Foods Inc. Protein methods and compositions

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565785A (en) * 1978-06-08 1986-01-21 The President And Fellows Of Harvard College Recombinant DNA molecule
DE2943016C2 (de) * 1979-10-24 1984-09-06 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Verfahren zur Reinigung von Interferon
JPS5815989A (ja) * 1981-06-12 1983-01-29 Sanki Eng Kk 生理活性蛋白質の精製方法
US4673641A (en) * 1982-12-16 1987-06-16 Molecular Genetics Research And Development Limited Partnership Co-aggregate purification of proteins
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
US4795706A (en) * 1985-01-31 1989-01-03 Eli Lilly And Company Novel expression control sequences
US4690892A (en) * 1985-04-29 1987-09-01 Union Carbide Corporation Process for the recycle of phase-forming liquids of multi-phase aqueous systems
DE3527268A1 (de) * 1985-07-30 1987-02-05 Biotechnolog Forschung Gmbh Verfahren zur reinigung und gegebenenfalls gewinnung von formiat-dehydrogenase (fdh) aus candida boidinii und fdh-haltiges produkt
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
IL86090A (en) * 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
US4843155A (en) * 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
DD288837A5 (de) * 1988-11-08 1991-04-11 Zi Fuer Mikrobiologie Und Experimentelle Therapie,De Verfahren zur anreicherung rekombinanter proteine
US5124444A (en) * 1989-07-24 1992-06-23 Microprobe Corporation Lactam-containing compositions and methods useful for the extraction of nucleic acids
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
DD298424A5 (de) * 1989-11-22 1992-02-20 Universitaet Leipzig,De Verfahren zur gewinnung von alkalischer phosphatase aus kaelberdarm
GB8927008D0 (en) * 1989-11-29 1990-01-17 Ciba Geigy Novel process for the production of unfused protein in e.coli
US5093254A (en) * 1990-01-23 1992-03-03 The United States Of America, As Represented By The Secretary Of Commerce Aqueous two-phase protein extraction
JPH06500084A (ja) * 1990-08-20 1994-01-06 ノボ　ノルディスク　アクティーゼルスカブ 生物学的に活性な化合物、その製造方法及びその利用
SE9003534D0 (sv) * 1990-11-06 1990-11-06 Kabigen Ab A method for isolating and purifying peptides and proteins
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide

Also Published As

Publication number Publication date
EP0714403A1 (en) 1996-06-05
DE69411015D1 (de) 1998-07-16
AU673624B2 (en) 1996-11-14
CA2167910A1 (en) 1995-03-02
CA2167910C (en) 2009-10-06
JP3646195B2 (ja) 2005-05-11
US5695958A (en) 1997-12-09
GR3027656T3 (en) 1998-11-30
ATE167193T1 (de) 1998-06-15
AU7561694A (en) 1995-03-21
DE69411015T2 (de) 1998-10-22
ES2119222T3 (es) 1998-10-01
WO1995006059A1 (en) 1995-03-02
EP0714403B1 (en) 1998-06-10
US5407810A (en) 1995-04-18
US5723310A (en) 1998-03-03
JPH09501931A (ja) 1997-02-25

Similar Documents

Publication Publication Date Title
DK0714403T3 (da) Vandig flerfaset isolering af polypeptid
AU578011B2 (en) A polycistronic expression vector for vertebrate cells
DK577783A (da) Vektor for udtrykkelse af et dna-segment i gaer
BR0010725A (pt) Expressão e exportação de proteìnas de interferon-alfa como proteìnas de fusão de fc
GB2007676A (en) Method and means for microbial polypeptide expression
DE69533317D1 (de) Isolierung von nukleinsäuren
CO5021164A1 (es) Genes de elongasa y sus usos
ATE130031T1 (de) Verwendungen viraler enzyme.
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
EA199700399A1 (ru) Способ крупномасштабной очистки плазмид
ATE24934T1 (de) Abtrennung von plasma-proteinen aus zellkultursystemen.
EP0247730A3 (en) Antibodies, their preparation and use and products containing them
AU2570892A (en) Method of separating oleophilic-hydrophobic material from wash water
KR970705408A (ko) 헤모필루스 부착 및 침투 단백질(haemophilus adherence and penetration proteins)
AU2529095A (en) Vaccine against mycobacterial infections
AU8215791A (en) Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance
BR9810650A (pt) Vetor para expressão de proteìna heteróloga e métodos para extrair proteìna recombinante e para purificar insulina recombinante isolada
KR890000667A (ko) 외래성 dna를 메틸 영양 요구성 세균에서 발현시키기 위한 프로모터, 이의 제조방법 및 이의 용도
GR3016996T3 (en) Method for the preparation of a protein by yeast using an inductible system, vectors and corresponding transformed strains.
Simonin et al. Improved Isolation of SlaA and SlaB S-layer proteins in Sulfolobus acidocaldarius
ATE469221T1 (de) Verbesserte stämme von enterobacteiaceae für fermentation
EP0112012A3 (en) Recombinant DNA molecules
Yaneva et al. Tissue specificity of tightly bound non-histone chromosomal proteins
Lugnier et al. Mechanism of ricin action on a wheat germ cell-free protein synthesizing system
KR860000378A (ko) α-인터페론의 분리 및 정제방법